Hepion Pharmaceuticals, Inc. (HEPA)
0.066
-0.01
(-7.11%)
USD |
OTCM |
Sep 03, 16:00
Hepion Pharmaceuticals Total Liabilities (Quarterly) : 0.6489M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6489M |
| March 31, 2026 | 0.8487M |
| December 31, 2025 | 0.4024M |
| September 30, 2025 | 0.4158M |
| June 30, 2025 | 0.7085M |
| March 31, 2025 | 2.422M |
| December 31, 2024 | 3.477M |
| September 30, 2024 | 4.122M |
| June 30, 2024 | 2.448M |
| March 31, 2024 | 8.468M |
| December 31, 2023 | 10.88M |
| September 30, 2023 | 8.844M |
| June 30, 2023 | 10.13M |
| March 31, 2023 | 12.34M |
| December 31, 2022 | 10.95M |
| September 30, 2022 | 10.44M |
| June 30, 2022 | 16.25M |
| March 31, 2022 | 9.219M |
| December 31, 2021 | 11.18M |
| September 30, 2021 | 8.959M |
| June 30, 2021 | 9.032M |
| March 31, 2021 | 6.182M |
| December 31, 2020 | 8.856M |
| September 30, 2020 | 7.491M |
| June 30, 2020 | 5.792M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.502M |
| December 31, 2019 | 4.247M |
| September 30, 2019 | 4.847M |
| June 30, 2019 | 5.310M |
| March 31, 2019 | 7.259M |
| December 31, 2018 | 6.214M |
| September 30, 2018 | 9.727M |
| June 30, 2018 | 8.727M |
| March 31, 2018 | 6.345M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | 11.79M |
| March 31, 2016 | 5.454M |
| December 31, 2015 | 5.662M |
| September 30, 2015 | 4.215M |
| June 30, 2015 | 1.938M |
| March 31, 2015 | 1.616M |
| December 31, 2014 | 0.361M |
| September 30, 2014 | 0.4647M |
| June 30, 2014 | 4.934M |
| March 31, 2014 | 9.986M |
| December 31, 2013 | 0.4987M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.927M |
| Shareholders Equity (Quarterly) | 1.278M |
| Current Ratio | 3.911 |
| Net Debt Paydown Yield | 5.33% |